Yes. The cell should be highlighted to indicate that it is calculated by IDSS.
HEDIS MY 2022
FAQ Directory: HEDIS
Filter Results
- Save
Save your favorite pages and receive notifications whenever they’re updated.
You will be prompted to log in to your NCQA account.
Save your favorite pages and receive notifications whenever they’re updated.
You will be prompted to log in to your NCQA account.
- Email
Share this page with a friend or colleague by Email.
We do not share your information with third parties.
Share this page with a friend or colleague by Email.
We do not share your information with third parties.
- Print
Print this page.
Print this page.
5.16.2022 MY 2022 Technical Update – COL-E Measure In the updated version of the COL-E measure that was re-released in the MY 2022 Technical Update, the “Total” data element listed in the age column is not highlighted in Table COL-E-A-3: Data Elements for Colorectal Cancer Screening. Should this cell be highlighted?
4.15.2022 Data Aggregator Validation (DAV) Data for ECDS Reporting Can validated DAV data streams be used for ECDS reporting? If yes, how should they be categorized (which SSoR)?
4.15.2022 Initiation and Engagement of Substance Use Disorder Treatment (IET) Should denominator episodes be deduplicated to one per day? For example, if a member has two outpatient visits with an SUD diagnosis on the same date of service (with different providers), is it one denominator episode or two?
4.15.2022 Data Aggregator Validation (DAV) Data for ECDS Reporting Can validated DAV data streams be used for ECDS reporting? If yes, how should they be categorized (which SSoR)?
2.15.2022 Guidelines for Calculations and Sampling: Hybrid Measures When reducing sample sizes for measures with stratifications, which are used: the total rates or the stratified rates?
2.15.2022 Cervical Cancer Screening (CCS) For cervical cancer screening, should we exclude transgender women (male to female, never had a cervix)?
Administrative data, codes in the Absence of Cervix Diagnosis Value Set (e.g., ICD-10-CM Diagnosis code Q51.5 [agenesis and aplasia of cervix]) may be used to exclude transgender members from the measure. If the medical record documents that the member was born male (e.g., transgender male to female), this is evidence that the member does not have a cervix, meets optional exclusion criteria and may be removed from the measure. Medical record documentation of cervical agenesis or clinical synonyms (e.g., evidence a patient was born without a cervix) may also be used to exclude these members. These members should remain in the measure if the organization is unable to find the appropriate documentation.
HEDIS MY 2021
2.15.2022 COVID-19 Is HEDIS changing data collection strategies for HEDIS MY 2021 due to COVID?
1.14.2022 Continuity of Care Documents Can Continuity of Care Documents (CCDs)/style sheets generated from CCDs be used for hybrid abstraction?
1.14.2022 Continuity of Care Documents Can Continuity of Care Documents (CCDs)/style sheets generated from CCDs be used for hybrid abstraction?
12.15.2021 General Guideline 32: Obtaining Information for the Systematic Sample Measures In which data element should exclusions be reported when exclusion information is found through a data refresh?
For HEDIS MY 2021 reporting, reporting exclusions in different categories found through a data refresh is flexible; for example, number of original sample records excluded because of valid data errors, number of administrative data records excluded and so on. Record counts must be able to be reconciled between the MRSS, the number of exclusions, records added from the oversample and the denominator.
HEDIS MY 2021